Skip to main content
Jessica (Ravikoff) Allegretti, MD, Gastroenterology, Boston, MA, Brigham and Women's Hospital

JessicaE(Ravikoff)AllegrettiMD

Gastroenterology • Boston, MA

Associate Director, Crohn’s and Colitis Center

Join to view full profile

Dr. Allegretti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Allegretti's full profile

Already have an account?

Summary

  • Dr. Jessica Allegretti is a gastroenterologist in Boston, MA and is affiliated with Brigham and Women's Hospital. She received her medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 8 years. She is experienced in inflammatory bowel disease.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Gastroenterology, 2012 - 2015
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2024
  • NH State Medical License
    NH State Medical License 2022 - 2024
  • RI State Medical License
    RI State Medical License 2022 - 2024

Publications & Presentations

PubMed

Lectures

  • Clostridium difficile: Are We Making Progress? 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/6/2018

Press Mentions

  • Four Analyses of Data for REBYOTA™ (Fecal Microbiota, Live – Jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection, Presented at DDW 2023
    Four Analyses of Data for REBYOTA™ (Fecal Microbiota, Live – Jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection, Presented at DDW 2023May 8th, 2023
  • FMT Tops Standard of Care for First or Second C. Diff Infections
    FMT Tops Standard of Care for First or Second C. Diff InfectionsSeptember 29th, 2022
  • Opinion: Splashing Cold Water on Poop Transplants for Weight Loss
    Opinion: Splashing Cold Water on Poop Transplants for Weight LossSeptember 1st, 2022
  • Join now to see all

Hospital Affiliations

Dr. Jessica Allegretti, Dr. Jessica Allegretti, MD, Dr. J Allegretti, Dr. Jessica E Allegretti